Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

A man's hair grew back to almost normal 7 months after COVID-19 without needing treatment.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

A man had nail and hair changes months after severe Covid-19, showing long-term effects.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

AGA linked to worse COVID-19 outcomes in men.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

COVID-19 may cause different types of hair loss, and the virus's effects on hair could help understand its impact on other body parts.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Higher androgen levels might make COVID-19 worse, especially in men.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Some alopecia treatments might help treat COVID-19, but more research is needed.